Trials / Completed
CompletedNCT01535417
Efficacy and Safety of Shinbaro Capsule
A 12 Weeks, Randomized, Double-blind, Multi-centers, Phase III Study to Evaluate the Efficacy and Safety of Shinbaro Capsule Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- Green Cross Corporation · Industry
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of 'Shinbaro Capsule', a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Shinbaro Capsule | Herbal drug (Ledebouriellae Radix, Achyranthis Radix, Acanthopanacis Cortex, Cibotii Rhizoma, Glycine Semen, Eucommiae Cortex) |
| DRUG | Celebrex |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2012-02-17
- Last updated
- 2012-02-17
Source: ClinicalTrials.gov record NCT01535417. Inclusion in this directory is not an endorsement.